| __timestamp | Novo Nordisk A/S | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13762000000 | 581800000 |
| Thursday, January 1, 2015 | 13608000000 | 671900000 |
| Friday, January 1, 2016 | 14563000000 | 876700000 |
| Sunday, January 1, 2017 | 14014000000 | 857900000 |
| Monday, January 1, 2018 | 14805000000 | 822200000 |
| Tuesday, January 1, 2019 | 14220000000 | 778200000 |
| Wednesday, January 1, 2020 | 15462000000 | 512600000 |
| Friday, January 1, 2021 | 17772000000 | 681000000 |
| Saturday, January 1, 2022 | 24047000000 | 662200000 |
| Sunday, January 1, 2023 | 32443000000 | 910700000 |
In pursuit of knowledge
In the competitive landscape of the pharmaceutical industry, innovation is key to staying ahead. Novo Nordisk A/S and Viatris Inc. are two giants in this field, but who truly leads in investing in research and development (R&D)? Over the past decade, Novo Nordisk has consistently outpaced Viatris in R&D spending. In 2023, Novo Nordisk's R&D expenses surged to nearly 32.4 billion, marking a staggering 135% increase from 2014. In contrast, Viatris's investment grew modestly, peaking at just over 910 million in 2023, a 56% rise from 2014. This significant disparity highlights Novo Nordisk's commitment to innovation, potentially driving future breakthroughs in diabetes care and other therapeutic areas. As the industry evolves, the strategic allocation of resources towards R&D will likely determine the leaders of tomorrow.
Novo Nordisk A/S or Pfizer Inc.: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Novo Nordisk A/S vs Amgen Inc.
Novo Nordisk A/S vs Vertex Pharmaceuticals Incorporated: Strategic Focus on R&D Spending
SG&A Efficiency Analysis: Comparing Novo Nordisk A/S and Viatris Inc.
Research and Development Investment: Novo Nordisk A/S vs Blueprint Medicines Corporation
Analyzing R&D Budgets: Novo Nordisk A/S vs ACADIA Pharmaceuticals Inc.
Novo Nordisk A/S or Bausch Health Companies Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Wave Life Sciences Ltd.
Research and Development Investment: Johnson & Johnson vs Viatris Inc.
Research and Development: Comparing Key Metrics for Neurocrine Biosciences, Inc. and Viatris Inc.
Viatris Inc. or BioMarin Pharmaceutical Inc.: Who Invests More in Innovation?
R&D Spending Showdown: Viatris Inc. vs Alkermes plc